These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6264368)

  • 21. The measurement of 2-thiothiazolidine-4-carboxylic acid as an index of the in vivo release of CS2 by dithiocarbamates.
    Johnson DJ; Graham DG; Amarnath V; Amarnath K; Valentine WM
    Chem Res Toxicol; 1996; 9(5):910-6. PubMed ID: 8828929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between cholestasis and hepatic lesions in chronic alcoholics (author's transl)].
    Uribarrena R; Amézaga A; Figuerido E; Zubicoa J; Borda F; Rivero Puente A
    Med Clin (Barc); 1982 Jan; 78(2):52-5. PubMed ID: 7070130
    [No Abstract]   [Full Text] [Related]  

  • 23. A rapid and simple radioactive method for the determination of disulfiram and its metabolites from a single sample of biological fluid or tissue.
    Faiman MD; Dodd DE; Nolan RJ; Artman L; Hanzlik RE
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):481-96. PubMed ID: 197575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon disulfide and N,N-diethyldithiocarbamate generate thiourea cross-links on erythrocyte spectrin in vivo.
    Erve JC; Amarnath V; Graham DG; Sills RC; Morgan AL; Valentine WM
    Chem Res Toxicol; 1998 May; 11(5):544-9. PubMed ID: 9585486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell status in alcoholic and non-alcoholic liver disease.
    Maruyama S; Hirayama C; Yamamoto S; Koda M; Udagawa A; Kadowaki Y; Inoue M; Sagayama A; Umeki K
    J Lab Clin Med; 2001 Nov; 138(5):332-7. PubMed ID: 11709657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma glycoprotein variations in alcoholic hepatopathies after an oral ethanol overload: preliminary study].
    Ibarra de la Rosa I; Blanco FJ; Caballero Plasencia AM; Mora Lara JR
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):309-15. PubMed ID: 4001525
    [No Abstract]   [Full Text] [Related]  

  • 27. Carbon disulfide in blood: a method for storing and analysing samples.
    Perbellini L; Maranelli G; Lombardini F; Gandini G; Brugnone F
    Med Lav; 1994; 85(2):171-8. PubMed ID: 8072446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
    Pagani A; Pranzo A; Sala N; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scanning electron microscopic studies on morphological abnormalities of erythrocytes in alcoholic liver diseases.
    Takashimizu S; Shiraishi K; Watanabe N; Numata M; Kawazoe K; Miyachi H; Tokunaga M; Akatuka A; Matsuzaki S
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):81S-86S. PubMed ID: 10803786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species.
    Burkitt MJ; Bishop HS; Milne L; Tsang SY; Provan GJ; Nobel CS; Orrenius S; Slater AF
    Arch Biochem Biophys; 1998 May; 353(1):73-84. PubMed ID: 9578602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of epinephrine on glucose metabolism in patients with alcoholic cirrhosis.
    Schricker T; Albuszies G; Weidenbach H; Beckh K; Ensinger H; Anhäupl T; Radermacher P; Vogt J; Adler G; Georgieff M
    Hepatology; 1996 Aug; 24(2):330-6. PubMed ID: 8690401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
    Bode C; Schäfer C; Fukui H; Bode JC
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B virus markers in alcoholic patients (author's transl)].
    Attali P; Thibault N; Buffet C; Briantais MJ; Papoz L; Chaput JC; Etienne JP
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1095-102. PubMed ID: 7319205
    [No Abstract]   [Full Text] [Related]  

  • 35. Divergence of ethanol and acetaldehyde kinetics and of the disulfiram-alcohol reaction between subjects with and without alcoholic liver disease.
    Wicht F; Fisch HU; Nelles J; Raisin J; Allemann P; Preisig R
    Alcohol Clin Exp Res; 1995 Apr; 19(2):356-61. PubMed ID: 7625569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis.
    Alvarez-Leal M; Contreras-Hernández D; Chávez A; Diaz-Contreras JA; Careaga-Olivares J; Zúñiga-Charles MA; Reynoso MC; Hernández-Téllez A
    Am J Hum Biol; 2001; 13(3):297-300. PubMed ID: 11460894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thyroid hormones in alcoholic cirrhosis before and after alcohol withdrawal].
    Rumilly F; Bigard MA; Dupuis D; Gaucher P
    Sem Hop; 1983 Feb; 59(6):390-6. PubMed ID: 6302875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of reversible hypertension during disulfiram therapy.
    Volicer L; Nelson KL
    Arch Intern Med; 1984 Jun; 144(6):1294-6. PubMed ID: 6732388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
    Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
    Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.